Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for preparing a medicament for normalizing serum lipids
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 24, 2004
app pub date -
Oct 8, 2003
filing date -
Jun 3, 1996
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Use of inhibitors of cellular Na.sup.+/H.sup.+ exchanger (NHE) for the production of a medicament for the normalization of serum lipids The active compounds identified as inhibitors of the cellular Na.sup.+/H.sup.+ exchanger (NHE are used for the production of a medicament for the normalization of serum lipids. They are used for the production of a medicament for lowering the blood lipid level and illnesses caused thereby, as well as of endothelial dysfunction syndrome and illnesses caused thereby.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully